Novo, Viking heat up MASH space with promising data at AASLD24
Pfizer, under pressure to change, names oncology head as new R&D chief
What might a Trump administration mean for the Biosecure Act?
Sage wilts as Huntington's prospect flunks trial
*please scroll down for all the latest news*
